AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT03191240

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03191240
Other papers using this trial's data
  • Diastolic blood pressures and end tidal carbon dioxides during cardiopulmonary resuscitations and their association with outcomes in adult out-of-hospital cardiac arrest patients: A preplanned secondary analysis of the Augmented Medication CardioPulmonary resuscitation (AMCPR) trial Resuscitation, 2025-05 DOI, PubMed 39952383

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03191240. Randomized; triple masking; primary purpose treatment. Start 2017-12-31 (actual); primary completion 2021-08-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA
Condition
Out-of-Hospital Cardiac Arrest
Intervention (Drug)
Vasopressins
Intervention (Drug)
Normal saline
Lead sponsor
Asan Medical Center (class: other)

Record details

Record id
cardio:ct-nct03191240
Content hash
7c46a3b708089f89ad48d9c24abcb53dba0f798ef91b0bb7ad74ccad3fc1f46c